Underlying Causes and Diagnostic Approach in Bronchiectasis

Epidemiology

• Approximately 40 %–74 % of patients with bronchiectasis have an identifiable underlying cause, highlighting the importance of a thorough etiologic work‑up. 1, 2

Classification by Anatomic Distribution

• The pattern of disease distribution (focal vs. diffuse) directly influences management decisions; recognizing the pattern guides whether local or systemic interventions are appropriate. 1

Focal Bronchiectasis – Local Interventions

• Focal bronchiectasis is often treatable with bronchoscopy or surgical resection, making early identification crucial for targeted therapy. 1
• The primary mechanism is bronchial obstruction, which may result from:
• Post‑infectious severe pneumonia can lead to focal bronchiectasis, although its incidence has declined with widespread antibiotic use. 1, 3

Diffuse Bronchiectasis – Systematic Investigation

• In diffuse disease, systematic investigation for underlying disorders influences management in roughly 37 % of cases, underscoring the need for comprehensive evaluation. 1

Major Underlying Etiologies

Infectious / Post‑Infectious

• Prior severe infections such as tuberculosis, adenovirus, pertussis, or measles are recognized precipitants of bronchiectasis. 1
• Chronic infection with non‑tuberculous mycobacteria, especially Mycobacterium avium complex (MAC), can underlie bronchiectasis. 1
• Allergic bronchopulmonary aspergillosis (ABPA) is an established cause that requires specific immunologic treatment. 1

Immunodeficiency States

• Congenital or acquired hypogammaglobulinemia (particularly IgG and its subclasses) predisposes to bronchiectasis. 1, 4
• Common variable immunodeficiency is a notable immunologic contributor. 5
• Human immunodeficiency virus (HIV) infection is associated with bronchiectasis development. 1

Genetic / Congenital Disorders

• Cystic fibrosis is likely the most common identifiable cause of bronchiectasis in the United States and Europe, warranting referral to specialized CF clinics. 4
• Primary ciliary dyskinesia and α1‑antitrypsin deficiency are additional genetic conditions linked to bronchiectasis. 1

Autoimmune / Inflammatory Conditions

• Rheumatoid arthritis and inflammatory bowel disease are autoimmune disorders that can be associated with bronchiectasis. 1

Aspiration / Inhalation

• Chronic aspiration and toxic inhalation exposures are recognized environmental contributors. 1

Idiopathic

• When no cause is identified, bronchiectasis is classified as idiopathic, accounting for approximately 38 %–43 % of cases. 1, 2

Clinical Implications of Systematic Evaluation (ACCP Guidelines)

• The American College of Chest Physicians (ACCP) recommends a systematic search for underlying etiologies because the results often enable disease‑specific therapies that may slow or halt disease progression in a substantial proportion of patients. 1, 4
• Specific management actions based on identified causes include: